AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26497495
Drug: Total neoadjuvant
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total neoadjuvant therapy (TNT) with FOLFOX/CAPEOX before induction neoadjuvant chemotherapy (INCT) or after consolidation neoadjuvant chemotherapy (CNCT), with 5‐FU or capecitabine‐based chemoradiation.
Trial: 21536947
Drug: midazolam (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam (0.3 mg/kg; max 15 mg)
Trial: 17721103
Drug: Drug conservation
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug conservation arm (CD4 T-cell-guided ART strategy)
Trial: 14562945
Drug: Three 20
RxNorm normalized name: THREE-LOBE SAGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three 20 mg intramuscular injections of a preS2/S vaccine (GenHevac‐B) on days 0, 30 and 60
Trial: 14562945
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no vaccine therapy)
Trial: 8684200
Drug: Fresh-frozen plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh-frozen plasma (FFP) 20 mL/kg followed by 10 mL/kg after 24 h
Trial: 8684200
Drug: Gelatin-based plasma
RxNorm normalized name: Gelatin
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatin-based plasma substitute 20 mL/kg followed by 10 mL/kg after 24 h
Trial: 8684200
Drug: Glucose (control)
RxNorm normalized name: GLUCOSE CONTROL
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose (control) 20 mL/kg followed by 10 mL/kg after 24 h
Trial: 6760980
Drug: Flunarizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (10 mg nocte)
Trial: 6760980
Drug: Pizotifen (2-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pizotifen (2-3 mg per day in three administrations)
Trial: 29528499
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate (ESL) 1200 mg daily
Trial: 29528499
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate (ESL) 1600 mg daily
Trial: 27464860
Drug: Oxycodone 140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 140 μg/kg (Group O/70)
Trial: 27464860
Drug: Oxycodone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 200 μg/kg (Group O/100)
Trial: 23431348
Drug: Xiaoqinglong granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiaoqinglong granules (XQLG) as add-on therapy to seretide
Trial: 18633426
Drug: Irbesartan high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan high-dose combination therapy
Trial: 16385103
Drug: Methodologic features
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methodologic features (slow titration, flexible dosing, minimizing concomitant analgesics, fewer study sites)
Trial: 9890409
Drug: Amrinone (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amrinone (1.5 mg/kg bolus in 30 min and then 10 microg/kg/min for 1 h 30 min)
Trial: 2015727
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (120 mg) and propranolol (80 mg) combination
Trial: 2015727
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (120 mg) and metoprolol (100 mg) combination
Trial: 2015727
Drug: Oral verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral verapamil (120 mg) and pindolol (5 mg) combination
Trial: 2015727
Drug: Beta-blockers (propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (propranolol, metoprolol, pindolol) alone
Trial: 2015727
Drug: Verapamil and
RxNorm normalized name: trandolapril and verapamil
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Verapamil and beta-blocker combinations
Trial: 2015727
Drug: All verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All verapamil and beta-blocker combinations
Trial: 19732888
Drug: Combined metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined metformin and clomiphene citrate
Trial: 31553833
Drug: Intravenous ustekinumab
RxNorm normalized name: Ustekinumab
DrugBank: Ustekinumab (DB05679)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous ustekinumab 130 mg
Trial: 31553833
Drug: Intravenous ustekinumab
RxNorm normalized name: Ustekinumab
DrugBank: Ustekinumab (DB05679)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous ustekinumab 6 mg/kg
Trial: 31553833
Drug: Subcutaneous ustekinumab
RxNorm normalized name: Ustekinumab
DrugBank: Ustekinumab (DB05679)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous ustekinumab 90 mg every 12 weeks
Trial: 31553833
Drug: Subcutaneous ustekinumab
RxNorm normalized name: Ustekinumab
DrugBank: Ustekinumab (DB05679)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous ustekinumab 90 mg every 8 weeks
Trial: 19470045
Drug: Water-soluble nail
RxNorm normalized name: Fungi-Nail
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water-soluble nail lacquer applied once daily on the affected fingernails of the left hand for 24 consecutive weeks
Trial: 12851662
Drug: 21 mg/day
RxNorm normalized name: nicotine 21 MG/Day 24HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg/day transdermal nicotine system
Trial: 8956390
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ketamine plus 0.5 mg morphine
Trial: 8956390
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group A (10 mL saline with no additive)
Trial: 1574977
Drug: Propofol (induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (induced with propofol and maintained with an infusion of propofol 12 mg/kg/h for the first 15 min, followed by 8 mg/kg/h)
Trial: 2932989
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 1 mg
Trial: 25864998
Drug: Intramedullary nailing
RxNorm normalized name: FUNGI NAIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramedullary nailing and antirotator proximal femoral nail implant (TST, Turkey)
Trial: 9890197
Drug: Group I
RxNorm normalized name: Platelet group IIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group I (sFas > or =2.06 ng/ml)
Trial: 9890197
Drug: Group II
RxNorm normalized name: Platelet group IIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group II (sFas <2.06 ng/ml)
Trial: 2672998
Drug: buzepide metiodide
RxNorm normalized name: buzepide metiodide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buzepide metiodide and haloperidol combination
Trial: 31307913
Drug: Genistein supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genistein supplementation (2 capsules daily for 12 weeks, each containing 54 mg genistein)
Trial: 31307913
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 capsules daily for 12 weeks)
Trial: 25643928
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (continuation of previous treatments such as moisturization, packing, and cautery)
Trial: 16734394
Drug: Isoflavone intake
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone intake (75 mg of isoflavone conjugates/day)
Trial: 16734394
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of isoflavone plus walking
Trial: 12658208
Drug: Inhaled epoprostenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled epoprostenol (60 microg)
Trial: 10573618
Drug: Preoperative subcutaneous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative subcutaneous heparin (Group B, 8 patients - 4 laparoscopic and 4 open)
Trial: 8706070
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers and diuretics
Trial: 1831397
Drug: High-dose medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose medroxyprogesterone acetate (MPA) 1000 mg i.m. daily for 15 days, followed by 1000 mg weekly
Trial: 1831397
Drug: Estramustine 280
RxNorm normalized name: estramustine 280 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estramustine 280 mg per os twice daily
Trial: 6918402
Drug: Mevinolin 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 6.25 mg twice daily for 4 weeks
Trial: 6918402
Drug: Mevinolin 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 12.5 mg twice daily for 4 weeks
Trial: 6918402
Drug: Mevinolin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 25 mg twice daily for 4 weeks
Trial: 6918402
Drug: Mevinolin 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin 50 mg twice daily for 4 weeks
Trial: 6918402
Drug: Mevinolin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mevinolin (all doses)
Trial: 3893605
Drug: Regular medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular medication (Control)
Trial: 20398378
Drug: Pre-operative fluid
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative fluid therapy
Trial: 16003036
Drug: Eccentric training
RxNorm normalized name: SYRINGE 60ML ECCENTRIC TIP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eccentric training (squats on a 25 degrees decline board, 3 x 15 repetitions twice daily for 12 weeks)
Trial: 8909736
Drug: diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: diclofenac sodium 100 mg (preoperative administration)
Trial: 8909736
Drug: diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: diclofenac sodium 100 mg (postoperative administration)
Trial: 8909736
Drug: diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: diclofenac sodium 100 mg (both pre- and postoperative)
Trial: 1869646
Drug: Topical masoprocol
RxNorm normalized name: masoprocol Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical masoprocol applied twice a day for 14 to 28 days
Trial: 1869646
Drug: Topical masoprocol
RxNorm normalized name: masoprocol Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical masoprocol
Trial: 6213376
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg MPA with 250 mg testosterone enanthate (TE) monthly injection
Trial: 30700274
Drug: HPV vaccination
RxNorm normalized name: HPV-16 trojan peptide vaccine
DrugBank: HPV-16 trojan peptide vaccine (DB17496)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccination (at least one dose)
Trial: 29473223
Drug: Subcrestal placement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcrestal placement of implants
Trial: 29473223
Drug: Epicrestal placement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epicrestal placement of implants
Trial: 23044236
Drug: 0.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/day ETV (group A)
Trial: 23044236
Drug: 0.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/day ETV maleate (group B)
Trial: 15983801
Drug: 50 ng/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 ng/ml ketamine
Trial: 15983801
Drug: Ketamine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (50 ng/ml or 100 ng/ml)
Trial: 1678941
Drug: Repetitive injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repetitive injections of vecuronium (Group 1)
Trial: 6343664
Drug: Cefotetan (CTT)
RxNorm normalized name: Cefotetan
DrugBank: Cefotetan (DB01330)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefotetan (CTT) 2g daily
Trial: 6343664
Drug: Cefmetazole (CMZ)
RxNorm normalized name: Cefmetazole
DrugBank: Cefmetazole (DB00274)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefmetazole (CMZ) 4g daily
Trial: 29962090
Drug: Web-based acceptance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based acceptance and commitment therapy (ACT) program (YOLO), 4 weeks
Trial: 27255908
Drug: Functional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional physical therapy program conducted over-ground (fPT)
Trial: 27255908
Drug: Maintenance therapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance therapy only
Trial: 17660490
Drug: VTE during
RxNorm normalized name: Pro-C-Dure 6 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VTE during chemotherapy
Trial: 16278629
Drug: Sequential combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential combined spinal-epidural (CSE) anesthesia
Trial: 11861034
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy (ERT) with conjugated estrogens 0.625 mg/day for 4 weeks
Trial: 11861034
Drug: Thrombin-stimulated platelets
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin-stimulated platelets (0.1 U/ml)
Trial: 11861034
Drug: Thrombin-stimulated platelets
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin-stimulated platelets (0.3 U/ml)
Trial: 10455479
Drug: Bisoprolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (5 mg once daily)
Trial: 10455479
Drug: Bendrofluazide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide (2.5 mg once daily)
Trial: 2611092
Drug: Intranasal lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal lignocaine (100 mg dose)
Trial: 2611092
Drug: Intravenous lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lignocaine (100 mg dose)
Trial: 31245885
Drug: Antibiotic prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylactic group (2 g of cefotiam during endoscopic injection)
Trial: 31245885
Drug: On-demand group
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand group (no prophylactic antibiotics)
Trial: 31245885
Drug: Antibiotic prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylactic group
Trial: 26314289
Drug: Telephone-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based treatment
Trial: 8874911
Drug: Neostigmine (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (0.07 mg/kg)
Trial: 3246212
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg trimethoprim (TMP)
Trial: 3246212
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg cinoxacin (CNO)
Trial: 30900815
Drug: 1.8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/d DHA+EPA
Trial: 30900815
Drug: 3.6 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 g/d EPA+DHA
Trial: 30900815
Drug: 4.2 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.2 g/d ALA
Trial: 30900815
Drug: 7.2 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.2 g/d ALA
Trial: 29871266
Drug: SLIT +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLIT + drug group (sublingual immunotherapy with Dermatophagoides farinae drops and symptomatic therapy)
Trial: 29871266
Drug: Drug group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug group (mometasone furoate nasal spray and desloratadine tablets)
Trial: 23598691
Drug: Zinc (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (50 mg per day for 4 months)
Trial: 21854273
Drug: Buprenorphine tapering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine tapering schedule
Trial: 18046666
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with ACEIs and ARBs
Trial: 18046666
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with ACEIs or ARBs
Trial: 14730412
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg deramciclane
Trial: 11563590
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment and secondary prophylaxis during PBSCT
Trial: 31122493
Drug: Co-careldopa (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-careldopa (125 mg after initial doses of 62.5 mg)
Trial: 20003341
Drug: Primary care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary care management (standard GP consultation, medication, advice and education)
Trial: 11472461
Drug: Captopril (angiotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (angiotensin converting enzyme inhibitor)
Trial: 11472461
Drug: Atenolol (beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (beta blocker)
Trial: 9735735
Drug: Warm-Up Active
RxNorm normalized name: Camphor (Synthetic) 5 mg in 100 g TOPICAL CREAM [ALLG Essentials Warm-up Accelerator]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warm-Up Active Wound Therapy
Trial: 9270567
Drug: Ropinirole (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirole (n = 116) starting dose of 0.25 mg tid, titrated to at least 1.5 mg tid (maximum dose, 8 mg tid)
Trial: 2930837
Drug: Daunorubicin (DNR)
RxNorm normalized name: daunorubicin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunorubicin (DNR) or 4‐(9‐acridinylamino)methanesulfan‐m‐anisidide (AMSA) in combination with arabinosylcytosine (Ara‐C) and 6‐thioguanine (TG)
Trial: 861135
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg digoxin tablets (Lanoxin)
Trial: 861135
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg digoxin in solution in soft gelatin capsules (Lanoxicaps)
Trial: 861135
Drug: Lanoxicaps (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanoxicaps (0.2 mg)
Trial: 25872532
Drug: Levothyroxine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine (25 mcg once daily, increased as needed to maintain TSH between 0.4 to 2.5 mU/L)
Trial: 23868627
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement containing Omega‐3, Policosanol, Resveratrol, L‐carnitine, Monascus purpureus, Coenzyme Q10, Vitamin B6 and Vitamin B12
Trial: 15575341
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal with dual-wave insulin bolus delivery
Trial: 15575341
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal with normal insulin bolus delivery
Trial: 15575341
Drug: Control meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control meal with normal insulin bolus delivery
Trial: 9422856
Drug: Anistreplase treatment
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anistreplase treatment
Trial: 8236505
Drug: IL-2 plus
RxNorm normalized name: IL-2
DrugBank: Human interleukin-2 (DB14865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 plus L-carnitine (1000 mg/day orally)
Trial: 18327427
Drug: Clarithromycin 15
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin 15 mg/kg/day, twice a day
Trial: 18327427
Drug: Erythromycin 30-50
RxNorm normalized name: erythromycin 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 30-50 mg/kg/day, four times daily
Trial: 16360994
Drug: IV NAC
RxNorm normalized name: NAC
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV NAC 300 mg
Trial: 16360994
Drug: IV NAC
RxNorm normalized name: NAC
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV NAC 600 mg
Trial: 8620338
Drug: Colestipol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (20 g/d)
Trial: 8620338
Drug: Colestipol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (20 g/d) + Simvastatin (20 mg/d)
Trial: 2015715
Drug: Intraoperative and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative and postoperative intravenous urokinase
Trial: 2015715
Drug: Long-term sodium
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term sodium warfarin therapy